Covered recipient · General Payments record
JOHN W WINKELMAN
Allopathic & Osteopathic Physicians Psychiatry & Neurology Sleep Medicine
General Payments · PY2019–2024
$100,860.91
- Reported across 44 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $34,786.75 | 4 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,677.50 | 1 |
| Food and Beverage | $79.93 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Azurity Pharmaceuticals, Inc. | $34,786.75 | 4 |
| IDORSIA PHARMACEUTICALS US INC | $2,757.43 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (6)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Azurity Pharmaceuticals, Inc. | $3,327.50 | 10/02/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1134014403 | CMS |
| Azurity Pharmaceuticals, Inc. | $12,402.50 | 11/02/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1134014405 | CMS |
| Azurity Pharmaceuticals, Inc. | $1,663.75 | 12/02/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1134014407 | CMS |
| Azurity Pharmaceuticals, Inc. | $17,393.00 | 12/02/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1150913304 | CMS |
| IDORSIA PHARMACEUTICALS US INC | $79.93 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146756155 | CMS |
| IDORSIA PHARMACEUTICALS US INC | $2,677.50 | 07/22/2024 | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Undisputed | 01/23/2026 | 1146756565 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.